Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medamicus expands with $18 million acquisition:

This article was originally published in Clinica

Executive Summary

Plymouth, Minnesota-based Medamicus has acquired the operating assets of Biomec Cardiovascular (BC) for $18m. The deal provides Medamicus with the means of developing and manufacturing implantable stimulation leads, lead delivery systems and accessories for cardiac rhythm management and neuromodulation. President and CEO Jim Hartman said that BC's sales had doubled in the first half of 2003 to $4.5m and expected this figure to grow to over $9m by the year-end. Minneapolis, Minnesota-based BC operated on a similar business model to Medamicus, coupling original equipment manufacturer sales coupled proprietory product development. This will enhance Medamicus's services to OEM customers such as Bard, Cook, Guidant, Medtronic and St Jude Medical, said Mr Hartman. BC is a subsidiary of privately held medical technology company Biomec, based in Cleveland, Ohio.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel